UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 9, 2022 (February 8, 2022) |
Ceridian HCM Holding Inc.
(Exact name of Registrant as Specified in Its Charter)
Delaware |
001-38467 |
46-3231686 |
||
(State or Other Jurisdiction
|
(Commission File Number) |
(IRS Employer
|
||
|
|
|
|
|
3311 East Old Shakopee Road |
|
|||
Minneapolis, Minnesota |
|
55425 |
||
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: (952) 853-8100 |
Not Applicable |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading
|
|
|
Common Stock, $0.01 par value |
|
CDAY |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers
On February 8, 2022, the Board of Directors (the “Board”) of Ceridian HCM Holding Inc. (the “Company”, or together with its subsidiaries, “Ceridian”) appointed Leagh Turner as co-Chief Executive Officer of the Company effective February 9, 2022. Ms. Turner will serve as co-Chief Executive Officer and she will continue to report to David Ossip, Chair and co-Chief Executive Officer of the Company.
Ms. Turner, 50, has served as President of the Company since August 2018 and Chief Operating Officer of the Company since February 2020. Prior to joining the Company, Ms. Turner held the position of global chief operating officer, strategic customer program of SAP from October 2016 to August 2018. Further, Ms. Turner has served as a member of the board of directors of Manulife Financial Corporation (“Manulife”) since November 10, 2020, and she serves on Management Resources and Compensation Committee and Risk Committee of the Manulife board.
In connection with her appointment as co-Chief Executive Officer, Ms. Turner’s base salary was increased from $655,000 to $800,000, and her annual target bonus was increased from 80% to 100% of her base salary, both effective January 1, 2022. It is anticipated that the annual long-term equity compensation would be the same for Ms. Turner's and Mr. Ossip's role as co-Chief Executive Officers of the Company.
In addition, Ceridian Canada Ltd., a wholly owned subsidiary of the Company and Ms. Turner entered into an amended and restated employment agreement effective February 9, 2022 (the “Amended and Restated Employment Agreement”). The Amended and Restated Employment Agreement reflects Ms. Turner’s appointment as Co-Chief Executive Officer, her increased base salary and annual target bonus percentage of her base salary, her ability to participate in the Company’s long-term equity incentive plan, and an executive coach of her choosing in an amount not to exceed $30,000. Further, the Amended and Restated Employment Agreement provides that if her employment is terminated without Cause or for Good Reason (as such terms are defined in the agreement), she will receive (i) a lump sum cash payment equal to eighteen months, if the termination occurs on or before September 4, 2025 or twenty four months, if the termination occurs after September 4, 2025 of total compensation (base salary plus incentive payment at target), (ii) executive outplacement services in an amount not to exceed $10,000, and (iii) continuation of medical, dental, and prescription healthcare coverage based on her termination date for eighteen months, if the termination occurs on or before September 4, 2025 or twenty four months, if the termination occurs after September 4, 2025. In addition, Ms. Turner’s employment agreement provides that if her employment is terminated due to death or Disability (as such term is defined in her employment agreement), she would receive a pro-rated portion of the variable incentive plan payment that she would have been entitled to receive for the fiscal year in which her death or Disability occurs had she remained continuously employed for the full fiscal year. Ms. Turner’s employment agreement also includes non-compete, non-recruitment and non-disparagement provisions.
The foregoing summary of the Amended and Restated Employment Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Amended and Restated Employment Agreement, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
As previously described pursuant to Item 404(a) of Regulation S-K in our Quarterly Report on Form 10-Q filed on November 3, 2021, Ceridian has an existing agreement with Manulife. Ms. Turner is a member of the board of directors of Manulife Financial Corporation. For the period January 1, 2021 to September 30, 2021, Ceridian paid approximately $1,500,000 to Manulife pursuant to that agreement.
Further, on February 8, 2022, the Board appointed Ms. Turner as a Class I director of the Board effective February 9, 2022. As a Class I director, Ms. Turner’s term on the Board will expire at the 2022 annual meeting of stockholders. As an employee director of the Company, Ms. Turner will not serve on any Board committee and will not participate in the compensation arrangements for non-employee directors of the Company.
In connection with the appointment of Ms. Turner to the Board, Ceridian entered into an indemnification agreement with Ms. Turner in the same form that Ceridian has entered into with its other directors. The indemnification agreement provides Ms. Turner with contractual rights to indemnification, expense advancement and reimbursement, to the fullest extent permitted under Delaware law, subject to certain exceptions contained in such agreement. A copy of the form of Indemnification Agreement is filed as Exhibit 10.11 to our Amendment No. 2 to Registration Statement on Form S-1, as filed with the Securities and Exchange Commission on April 12, 2018.
A copy of the Press Release issued by the Company in connection with Ms. Turner’s appointment as co-Chief Executive Officer and as a member of the Board is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in the press release attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
On February 8, 2022, the Board of Directors of the Company amended and restated the Amended and Restated Bylaws of Ceridian HCM Holding Inc. (the “Second Amended and Restated Bylaws”) to allow for up to two Chief Executive Officers of the Company.
The foregoing summary and description of the Second Amended and Restated Bylaws does not purport to be completed and is qualified in its entirety by reference to the full text of the Second Amended and Restated Bylaws, a copy of which is filed as Exhibit 3.1 with this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. |
Description of Exhibit
|
3.1 |
|
10.1 |
|
99.1 |
|
104 |
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
CERIDIAN HCM HOLDING INC. |
|
|
|
|
Date: |
February 9, 2022 |
By: |
/s/ William E. McDonald |
|
|
Name: Title: |
William E. McDonald
|
Exhibit 3.1
SECOND AMENDED AND RESTATED BYLAWS OF
CERIDIAN HCM HOLDING INC.
AS ADOPTED ON February 8, 2022
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
These Bylaws may be altered, amended or repealed, in whole or in part, or new Bylaws may be adopted by the stockholders or by the Board of Directors, provided, however, that notice of such alteration, amendment, repeal or adoption of new Bylaws be contained in the notice of such meeting of stockholders or Board of Directors as the case may be. All such amendments must be approved by either the holders of shares entitled to vote thereon or by a majority of the Board of Directors then in office, in each case, in accordance with the Certificate of Incorporation and applicable law.
If there is a conflict between the provisions of these Bylaws and the provisions of the Certificate of Incorporation or the mandatory provisions of the DGCL, such provision or provisions of the Certificate of Incorporation and the DGCL, as the case may be, will be controlling.
17
Exhibit 10.1
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
This Agreement is made with effect as of the 9th day of February, 2022.
BETWEEN:
CERIDIAN CANADA LTD.,
(“Ceridian Canada”)
- and -
LEAGH E. TURNER
(“Executive”)
WHEREAS, Ceridian Canada and Executive entered into an Employment Agreement, dated as of August 7, 2018, and as amended effective February 3, 2020 (the “Employment Agreement”); and
WHEREAS, Ceridian Canada and Executive desire to amend and restate the Employment Agreement in connection with Executive assuming the role of Co-Chief Executive Officer of Ceridian.
NOW, THEREFORE, in consideration of the premises, Executive’s promotion to Co-Chief Executive Officer with the enhanced compensation related to the same, and for other good and valuable consideration, the receipt and sufficiency whereof is hereby acknowledged by the parties hereto, the parties agree to the following:
In this Amended and Restated Employment Agreement (the “Agreement”), unless something in the subject matter or context is inconsistent therewith, all defined terms shall have the meanings set forth below:
Page 1
Page 2
Notwithstanding the foregoing, “Confidential Information” does not include any information which is now or subsequently becomes properly generally publicly available or in the public domain; is independently made available to Executive in good faith by a third party who has not violated a confidential relationship with Ceridian; or is required to be disclosed by law or legal process. Notwithstanding the foregoing, information which is made generally publicly available by or with the aid of Executive outside the scope of employment or contrary to the requirements of this Agreement and reasonable business practice will not be generally publicly available or in the public domain for the purposes of this Agreement.
Page 3
Page 4
Future Long-term equity incentive grants will reflect levels of competitiveness consistent with Ceridian’s compensation philosophy. The specific objectives and success criteria of the long-term equity incentive shall be timely established by Ceridian in good faith each year, subject to change from time to time, in its sole discretion. Ceridian shall have the right to alter, amend or discontinue any long-term equity incentive plan or Executive’s participation therein, with or without prior notice and without compensation to Executive, provided the changes are consistent with those affecting other employees at Executive’s same or similar level and the Executive acknowledges and agrees that such changes will not constitute a constructive dismissal of the Executive’s employment.
All equity contemplated under this Section 3.06 shall be provided subject to and in conformity with the provisions of the Ceridian HCM Holding Inc. 2018 Equity Incentive Plan (and / or such other agreements as may be required by Ceridian HCM Holding) to be entered into between Executive and Ceridian HCM Holding.
Page 5
Page 6
As used in this Section 4.02(a), “Total Compensation” shall mean an amount equal to Executive’s Base Salary plus Executive’s annual payment under the Incentive Plan (at target), divided by 12 to derive at the monthly amount which will be multiplied by the number of months payable as contemplated in (i) and (ii) above, respectively.
Page 7
Such coverage will be effective upon the general release of claims to be executed by the Executive (as contemplated in Section 4.05 below), on a retroactive basis from your effective termination date, and will continue for the period of time specified in (i) or (ii) above (as applicable), or until Executive becomes eligible to participate in any other group health insurance program (whichever occurs first). Executive agrees to provide notice to Ceridian as soon as reasonably possible of his/her eligibility to participate in any other group health insurance program.
Page 8
Page 9
NON-COMPETITION, NON-RECRUITMENT, NON-DISPARAGEMENT
Page 10
Page 11
Page 12
Page 13
[Remainder of Page Left Intentionally Blank]
Page 14
IN WITNESS WHEREOF the parties hereto have caused this Agreement to be duly executed and delivered as of the day and year first above written.
CERIDIAN CANADA LTD.
Per: /s/ David Ossip
Name: David Ossip
Title: Chief Executive Officer
Ceridian Canada Ltd.
Attn: Legal Department
5th Floor - 125 Garry Street
Winnipeg, MB R3C 3P2
EXECUTIVE
/s/ Leagh E. Turner
Leagh E. Turner
Address:
APPENDIX A
Privacy Guidelines & Pledge of Confidentiality
As an employee of Ceridian Canada Ltd. or one of its affiliates (collectively “Ceridian”), you will be in a position of trust and confidence, and will have access to and become familiar with Confidential Information (as that term is defined in the Employment Agreement to which this Appendix is attached) created, developed, used by or in possession of Ceridian. The unauthorized uploading, downloading, transfer, disclosure to or unauthorized use by third parties of any Confidential Information, or your unauthorized use of such information, could seriously harm Ceridian’s business and cause monetary loss that would be difficult, if not impossible, to measure.
Ceridian is sensitive to the necessity of maintaining the confidentiality of Confidential Information. Ceridian recognizes both the inherent right to privacy of every individual and its obligation to preserve the confidentiality of Confidential Information kept in its files. Ceridian is also aware of the concerns about individual privacy and perceived possible abuses of Confidential Information kept in automated data banks and other forms. Ceridian has, therefore, established privacy guidelines to ensure the protection, to the best of Ceridian’s ability, of all Confidential Information in its possession, in whatever form it is kept, whether it be an automated data bank, manual (or paper) file, microfiche or any other form. Accordingly, all Confidential Information in the possession of Ceridian, whether from clients or from Ceridian’s own employees or contractors, must be handled and protected in accordance with the following principles:
1. The independent consideration which you shall be entitled to receive in consideration of agreeing to the terms of this Appendix, shall consist of employment by Ceridian in accordance with Ceridian’s written offer of employment. You acknowledge that the foregoing independent consideration consists of real, bargained-for benefits to which you would have no entitlement but for your agreement to be bound by the terms set forth in this Appendix. You further acknowledge that you were not entitled to receive the foregoing independent consideration prior to agreeing to the terms of this Appendix. The terms of this Appendix shall and do form an integral part of the terms of your employment with Ceridian, and shall be considered incorporated into the terms of your offer of employment and / or employment agreement with Ceridian.
2. You acknowledge Ceridian’s representation that it has taken and intends to take reasonable measures to preserve the secrecy of its Confidential Information, including, but not limited to, requiring you to agree to the terms of this Appendix, as a condition of and part of the terms of your employment with Ceridian. You will hold all Confidential Information in the strictest confidence, and will not directly or indirectly copy, reproduce, disclose or divulge, or permit access to or use of, or obtain any benefit from, the Confidential Information or directly or indirectly use the Confidential Information other than as (a) as reasonably required to perform your duties as an employee of Ceridian, or (b) in the reasonable conduct of the business and your role within the business. For greater certainty, you shall not use the Confidential Information directly or indirectly upload, download, copy, transfer in any business other than the business of Ceridian, without the prior written consent of Ceridian. Confidential Information is the exclusive property of Ceridian or its Clients (as the case may be), and you will not divulge any Confidential Information to any person except to Ceridian’s qualified employees or advisers or other third parties with whom Ceridian has confidential business relations, and you will not, at any time, use Confidential Information for any purpose whatsoever, except as required to perform your duties as an employee of Ceridian or in the reasonable conduct of the business or your role within the business. Without limiting the generality of the foregoing, you acknowledge and agree that Confidential Information received from a Client is to be used only for the purposes intended by the Client when entering into an agreement with Ceridian, and will not be uploaded, downloaded, copied, transferred or used for any other purpose. Confidential Information will only be kept for the limited period of time necessary for Ceridian to fulfil its obligations. Regardless of the reason for termination of your employment (and whether or not you or Ceridian terminate the employment relationship): (a) you will not after the term of your employment, disclose Confidential Information which you may learn or acquire during your employment to any other person or entity or use any Confidential Information for your own benefit or for the benefit of another;
and (b) you will immediately deliver to Ceridian all property and Confidential Information in your possession or control which belong to Ceridian.
3. You acknowledge that your breach of the terms of this Appendix may cause irreparable harm to Ceridian and that such harm may not be compensable entirely with monetary damages. If you violate the terms of this Appendix, Ceridian may seek injunctive relief or any other remedy allowed at law, in equity, or under the terms of this agreement. In connection with any suit by Ceridian hereunder, Ceridian shall be entitled to an accounting, and to the repayment of all profits, compensation, commissions, fees or other remuneration which you have realized, as a result of the violation of the terms of this agreement which is the subject of the suit. In addition to the foregoing, Ceridian shall be entitled to collect from you any reasonable attorney’s fees and costs incurred by Ceridian in bringing any successful action against you or in otherwise successfully enforcing the terms hereof against you. You acknowledge and agree that nothing herein shall affect Ceridian’s rights to bring an action in a court of law for any legal claim against any third party who aids you in violating the terms of this agreement or who benefits in any way from your violation hereof.
4. You understand and agree that the terms of this Appendix shall apply no matter when, how or why your employment terminates and regardless whether the termination is voluntary or involuntary, and that the terms shall survive the termination of your employment.
5. If any one or more of the terms of this Appendix are deemed to be invalid or unenforceable by a court of law, the validity, enforceability and legality of the remaining provisions will not, in any way, be affected by or impaired thereby; and, notwithstanding the foregoing, all provisions hereof shall be enforced to the extent that is reasonable.
6. Ceridian’s decision to refrain from enforcing a breach of any term of this Appendix will not prevent Ceridian from enforcing the terms hereof as to any other breach that Ceridian discovers and shall not operate as a waiver against any future enforcement of any part of this Appendix, any other agreement with you or any other agreement with any other employee of Ceridian.
7. You hereby represent and agree with Ceridian that: (a) you are not bound or restricted by a non-competition agreement, a confidentiality or non-disclosure agreement, or any other agreement with a former employer or other third party, which would conflict with the terms of this offer; and (b) you will not use any trade secrets or other intellectual property belonging to any third party while performing services for Ceridian; and (c) you are of legal age, under no legal disability, have full legal authority to enter into this agreement and have had a reasonable and adequate opportunity to consult with independent counsel regarding the effect of this Appendix, the sufficiency of the independent consideration provided to you, and the reasonableness of the restrictions set forth herein.
Ceridian employs a Privacy Officer who is charged with ensuring that Ceridian complies with all privacy-related obligations imposed by statute or contract. Any questions regarding the collection, use, access, disclosure, retention or destruction of Confidential Information should be directed to the Privacy Officer.
Adherence to the guidelines set out above is a requirement for continued employment with Ceridian. Material breaches of these guidelines may result in discipline up to and including dismissal, or in the case of contractors, cancellation of your contract with Ceridian.
APPENDIX B
Intellectual Property Agreement
In consideration of Ceridian Canada Ltd. or one of its affiliates (collectively “Ceridian”) offering me employment, I hereby expressly acknowledge and agree as follows:
Exhibit 99.1
Leagh Turner Promoted to Co-CEO and Appointed to Board of Directors of Ceridian
Toronto, ON and Minneapolis, MN, February 9, 2022 - Ceridian (NYSE: CDAY; TSX: CDAY), a global leader in human capital management (HCM) technology, today announced it has promoted Leagh Turner to Co-CEO and has also appointed her to the Ceridian Board of Directors, effective immediately. Turner has served as President and Chief Operating Officer since 2018.
“Leagh is an incredible leader who has made a profound impact helping our customers transform their organizations, while successfully driving execution throughout our company,” said David Ossip, Chair and Co-CEO, Ceridian. “I believe that this modern structure will make Ceridian even more relevant for our customers. Together, Leagh and I will lead Ceridian into the next wave of growth.”
“Ceridian is a truly special organization with a clear purpose, core values that guide our actions every day, and a deep commitment to our customers,” said Leagh Turner, Co-CEO, Ceridian. “I’m honored to join David as Co-CEO and continue our ambitious goal helping organizations and millions of people around the world navigate the new world of work.”
In the expanded role for Turner, she will continue to fully drive the end-to-end operations and strong execution that are fundamental to Ceridian’s growth. Turner will continue reporting to Ossip, as Chair and Co-CEO.
Ossip will oversee key areas of growth for the business, with a primary focus on keeping Ceridian in the forefront of innovation. He will spend his time on product innovation and the growing opportunity with Dayforce Wallet, including helping the company expand Dayforce Wallet to the extended workforce. Additionally, Ossip will continue to spend significant time with prospects and the company’s global community of customers, as organizations of all sizes face the most significant workforce transformation in decades.
The Co-CEO model formalizes how Ossip and Turner have run the company during the last three years, and it further structures how the pair will drive the company’s long-term growth together.
“We believe this is what a modern, future-focused company should look like,” added Ossip. “I love our company, and I’ve never been more committed and excited about our future.”
About Ceridian
Ceridian. Makes Work Life Better.
Ceridian HCM Holding Inc. (NYSE: CDAY; TSX: CDAY) is a global human capital management software company. Dayforce, our flagship cloud HCM platform, provides human resources, payroll, benefits, workforce management, and talent management functionality. Our platform is used to optimize management of the entire employee lifecycle, including attracting, engaging, paying, deploying, and developing people. Ceridian has solutions for organizations of all sizes.
Source: Ceridian HCM Holding Inc.
For more information, contact:
Investor Relations:
1-844-829-9499
investors@ceridian.com
Public Relations:
Teri Murphy
1-647-417-2117
teri.murphy@ceridian.com